Trials / Unknown
UnknownNCT03290690
Positive Predictive Value (PPV) of Pseudomonas Aeruginosa
A Prospective, Single-blind Evaluation of the Positive Predictive Value (PPV) of the MolecuLight i:X™ Imaging Device to Predict the Presence of Pseudomonas Aeruginosa in Chronic Wounds
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (estimated)
- Sponsor
- MolecuLight Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-randomized, single-blind post market clinical follow-up study for which 65 patients will be imaged at Rouge Valley Centenary Hospital (Scarborough and Rouge Hospital) who present with a chronic wound and are receiving standard wound care treatment. The MolecuLight i:X imaging device will be used by the study clinician as an adjunctive tool in the assessment of the wound and will be used to guide the targeted sampling of a wound (with curettage scraping), as per current standard of care in the principal investigator's wound care clinic. The acquired tissue sample will then be analysed using conventional gold standard semi-quantitative culture methods to determine bacterial species present, also as per current standard of care in this clinic.
Conditions
Timeline
- Start date
- 2017-08-04
- Primary completion
- 2020-07-30
- Completion
- 2020-07-30
- First posted
- 2017-09-25
- Last updated
- 2020-03-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03290690. Inclusion in this directory is not an endorsement.